A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+1.33%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
Cap. Flow
+$5.74M
Cap. Flow %
3.47%
Top 10 Hldgs %
90.81%
Holding
19
New
2
Increased
–
Reduced
1
Closed
1

Top Buys

1
CLLS
Cellectis
CLLS
$3.1M
2
ADAP
Adaptimmune Therapeutics
ADAP
$3.01M

Top Sells

1
ACHV icon
Achieve Life Sciences
ACHV
$249K
2
SLRX icon
Salarius Pharmaceuticals
SLRX
$120K

Sector Composition

1 Healthcare 88.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CHMA
1
DELISTED
Chiasma, Inc. Common Stock
CHMA
$40.7M 24.56% 2,080,595 – –
TARA icon
2
Protara Therapeutics
TARA
$120M
$31.3M 18.88% 2,017,872 – –
PRTK
3
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$24.7M 14.9% 1,301,413 – –
SIEN
4
DELISTED
Sientra, Inc.
SIEN
$13M 7.86% 2,199,012 – –
CEMP
5
DELISTED
Cempra, Inc.
CEMP
$11.9M 7.21% 383,935 – –
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11.2M 6.77% 945,757 – –
TBRA
7
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$5.9M 3.56% 589,244 – –
EVAR
8
DELISTED
Lombard Medical, Inc.
EVAR
$4.45M 2.68% 3,473,452 – –
INNL
9
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$4.18M 2.52% 555,555 – –
CLLS
10
Cellectis
CLLS
$258M
$3.1M 1.87% +100,000 New +$3.1M
ADAP
11
Adaptimmune Therapeutics
ADAP
$15.6M
$3.01M 1.82% +250,000 New +$3.01M
RGLS
12
DELISTED
Regulus Therapeutics
RGLS
$2.85M 1.72% 327,350 – –
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
$2.67M 1.61% 1,600,000 – –
DERM
14
DELISTED
Dermira, Inc.
DERM
$2.42M 1.46% 70,000 – –
ANTH
15
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$2.03M 1.23% 437,994 – –
CCXI
16
DELISTED
ChemoCentryx, Inc.
CCXI
$1.74M 1.05% 215,000 – –
ACHV icon
17
Achieve Life Sciences
ACHV
$152M
$475K 0.29% 396,104 -207,636 -34% -$249K
EPRS
18
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$24K 0.01% 7,896 – –
SLRX icon
19
Salarius Pharmaceuticals
SLRX
$2.94M
– – -10,000 Closed -$120K